A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Publication | Open Access

DOI Full Paper Access

Citations

References

2017

Year

Colin Reisner, Leonardo M. Fabbri, Edward Kerwin, Charles Fogarty, Selwyn Spangenthal, Klaus F. Rabe, Gary T. Ferguson, Fernando J. Martínez, James F. Donohue, Patrick Darken,

Respiratory Research

Abstract

References